HIV Abdominal Obesity & Insulin Resistance: Treatment with IGF-1/IGFBP-3

Описание к видео HIV Abdominal Obesity & Insulin Resistance: Treatment with IGF-1/IGFBP-3

Effects of treatment with IGF-1/IGFBP-3 on glucose metabolism and fat distribution in HIV-infected patients with abdominal obesity and insulin resistance as and option to Human Growth Hormone with it's undesired side effects.

Maury Schambelan, University of California San Francisco, interviewed by Jeff Taylor at the Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, London, November 2008

Комментарии

Информация по комментариям в разработке